New 'Infusion Clinics' for Cheaper, Easier Biologics Delivery
Active Care Network and biotech partners aim to increase patient compliance.
TB 'Superbug' Case Highlights New-Drug Void
Drug makers find it hard to recoup development costs, report finds.
Pitch Blitz for Dry-Eye Drops Raises Allergan's Profile, Profits
Restasis goes against the grain of Rx-to-OTC switching.
